Hidden Leverage in Nonfinancial Corporations
International Finance Discussion Paper · 2026-07 · (1441) · 1-1
DOI: 10.17016/ifdp.2026.1441 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Finance Discussion Paper, 2026-07. Verfasst von Cody Kallen.
Abstract (Originalsprache)
A substantial portion of corporate debt remains hidden from balance sheets. I document two forms of off-balance-sheet leverage in nonfinancial corporations: operating leases (pre-2019) and intraperiod borrowing—short-term debt issued and repaid within reporting periods, which I am the first to study in nonfinancial firms. Approximately 29 percent of publicly traded firms used substantial operating leases and 12 percent show evidence of substantial intra-period borrowing, with a disproportionate subset using both types of hidden debt. Firms using substantial hidden leverage are generally smaller, more reliant on short-term funding, are less monitored by sophisticated market participants, and report lower leverage, suggesting they use off-balance-sheet debt to project false leverage profiles. When accounting changes in 2019 revealed substantial operating leases, affected firms subsequently cut capital expenditures by 25 percent and R&D by 14 percent, faced heightened risks of executive turnover and stakeholder scrutiny, and experienced more frequent accounting problems. Critically, revelation of substantial operating leases caused these exposed firms to curtail their intra-period borrowing and to raise their reported non-lease leverage.
Zitieren
APA
Kallen, C. (2026). Hidden Leverage in Nonfinancial Corporations. International Finance Discussion Paper, 1-1. https://doi.org/10.17016/ifdp.2026.1441
Vancouver
Kallen C. Hidden Leverage in Nonfinancial Corporations. International Finance Discussion Paper. 2026:1-1. doi:10.17016/ifdp.2026.1441
BibTeX
@article{Kallen2026,
author = {Kallen, Cody},
title = {Hidden Leverage in Nonfinancial Corporations},
journal = {International Finance Discussion Paper},
year = {2026},
number = {1441},
pages = {1--1},
doi = {10.17016/ifdp.2026.1441}
}
EUVIMED